Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

In vivo evolution of tigecycline resistance in ST540 carbapenem-resistant Acinetobacter baumannii: Mechanisms and global epidemiological perspective.

International journal of antimicrobial agents·2026
Same author

Retraction notice to "Economic and health impacts of PM2.5 pollution in China's urban air: Assessing the financial burden" [Ecotoxicol. Environ. Saf. 303C (2025) 118575].

Ecotoxicology and environmental safety·2026
Same author

Cell-free chromatin state tracing reveals disease origin and therapy responses.

Nature·2026
Same author

A human liver organoids-on-chip for the assessment of drug-induced liver injury.

BMC pharmacology & toxicology·2026
Same author

Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.

Frontiers in immunology·2025
Same author

A novel MOFs-functionalized microelectrode-based biosensor for real-time monitoring of hydrogen peroxide from tumor cells.

Biosensors & bioelectronics·2025

相关实验视频

Updated: Jul 10, 2025

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

6.6K

低度的塞沃弗劳兰降低了慢性阻塞性肺病 (COPD) 相关基因促进器的DNA甲基化,在COPD大鼠中.

Chuanxin Yang1, Libing Deng1, Fang Bao1

  • 1Department of Anesthesiology, Qingpu Branch of Zhongshan, Fudan University, Shanghai, China.

COPD
|November 27, 2023
PubMed
概括

低度的黄素可能通过低甲基化膜II型 (ATII) 细胞中的特定基因,从表观遗传学上受益慢性阻塞性肺病 (COPD). 高度显示相反的效果,表明COPD治疗中吸入麻醉剂的剂量依赖表观遗传机制.

关键词:
慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.通过DNA甲基化.在 DNMT1 中,DNMT1 是一个字符串.在 REC8 中使用.七伏氨酸是什么意思

更多相关视频

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.8K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.3K

相关实验视频

Last Updated: Jul 10, 2025

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

6.6K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.8K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.3K

科学领域:

  • 肺部医学 肺部医学
  • 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
  • 麻醉学 麻醉学

背景情况:

  • 慢性阻塞性肺病 (COPD) 是一种复杂的呼吸系统疾病,表观遗传机制不明,受吸入麻醉剂的影响.
  • 塞沃兰在COPD中的作用是有争议的,其影响因度而异,其潜在的表观遗传影响在很大程度上仍未知.

研究的目的:

  • 为了研究sevoflurane对COPD相关基因甲基化的剂量依赖性表观遗传效应,在膜II型 (ATII) 细胞中.
  • 阐明DNA甲基转移酶1 (DNMT1) 和REC8介质重组蛋白 (REC8) 在COPD中sevoflurane诱导的表观遗传修饰中的作用.

主要方法:

  • 建立由脂聚糖 (LPS) 诱导的慢性慢性肺炎大鼠模型和ATII细胞的隔离.
  • 对关键COPD相关基因 (Sftpa1,Napsa,Ca2,Sfta2,Lamp3,Wif1,Pgc,Etv5) 的促进子区域中的DNA甲基化模式的分析.
  • 评估DNMT1和REC8对目标基因促进体的结合以及与转录活性的相关性.

主要成果:

  • 低度 (0.5%) 的血清氨酸诱导了ATII细胞中六种COPD相关基因促进者的低甲基化,增加了它们的转录活性.
  • 高度 (2%) 的赛沃氨酸导致相同基因促进体的高甲基化,降低了转录活性.
  • 对于这些甲基化变化来说,DNMT1的结合是至关重要的,而REC8在低度的血清治疗细胞中,特别结合促进体,与DNMT1.1具有积极的相关性.

结论:

  • 在COPD模型中,sevoflurane对ATII细胞表现出剂量依赖的表观遗传效应,低度可能通过低甲基化提供治疗效益.
  • 这些发现突出了一个涉及DNMT1和REC8的新型表观遗传机制,为COPD的发病和麻醉治疗提供了洞察力.